137 related articles for article (PubMed ID: 21534157)
21. The ethics of clinical research in the Third World.
Angell M
N Engl J Med; 1997 Sep; 337(12):847-9. PubMed ID: 9295243
[No Abstract] [Full Text] [Related]
22. Improving subject recruitment by maintaining truly informed consent: a practical benefit of disclosing adverse clinical trial results.
Shah KR; Batzer FR
Am J Bioeth; 2009 Aug; 9(8):36-7. PubMed ID: 19998157
[No Abstract] [Full Text] [Related]
23. Ethical considerations.
Treiman DM
Epilepsy Res Suppl; 1993; 10():137-48. PubMed ID: 8251089
[No Abstract] [Full Text] [Related]
24. Legal and ethical aspects of clinical trials: the views of researchers.
Ferguson PR
Med Law Rev; 2003; 11(1):48-66. PubMed ID: 14606472
[No Abstract] [Full Text] [Related]
25. Can research subjects of clinical trials in developing countries sue physician-investigators for human rights violations?
Todres J
N Y Law Sch J Hum Rights; 2000; 16(3):737-68. PubMed ID: 12645593
[No Abstract] [Full Text] [Related]
26. The duty to disclose adverse clinical trial results.
Liao SM; Sheehan M; Clarke S
Am J Bioeth; 2009 Aug; 9(8):24-32. PubMed ID: 19998154
[TBL] [Abstract][Full Text] [Related]
27. Moral status and the fetus: continuation of a dialogue.
Strong C
Am J Bioeth; 2011 May; 11(5):52-4. PubMed ID: 21534153
[No Abstract] [Full Text] [Related]
28. Traveling across borders--the pitfalls of clinical trial regulation and stem cell exceptionalism.
Hauskeller C; Wilson-Kovacs D
Am J Bioeth; 2010 May; 10(5):38-40. PubMed ID: 20461647
[No Abstract] [Full Text] [Related]
29. Women and HIV/AIDS research: the barriers to equity.
Levine C
IRB; 1991; 13(1-2):18-22. PubMed ID: 11659324
[No Abstract] [Full Text] [Related]
30. An ethical framework for fetal research.
Chervenak FA; McCullough LB
Med Ethics (Burlingt Mass); 2003; 10(1):1-2. PubMed ID: 16175721
[No Abstract] [Full Text] [Related]
31. Abortion bans premised on fetal pain capacity.
Watson K
Hastings Cent Rep; 2012; 42(5):10-1. PubMed ID: 22976403
[No Abstract] [Full Text] [Related]
32. Extend the reach of institutional review boards first, then strengthen their depth.
Spike J
Am J Bioeth; 2008 Nov; 8(11):11-2. PubMed ID: 19061097
[No Abstract] [Full Text] [Related]
33. AZT trials and tribulations.
Crouch RA; Arras JD
Hastings Cent Rep; 1998; 28(6):26-34. PubMed ID: 9868608
[No Abstract] [Full Text] [Related]
34. Ethics and fetal research.
Callahan S; Chervenak FA; McCullough LB
Med Ethics (Burlingt Mass); 2003; 10(2):10-1. PubMed ID: 16175729
[No Abstract] [Full Text] [Related]
35. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
Vanderpool HY
Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
[TBL] [Abstract][Full Text] [Related]
36. Informed consent: the FDA's perspective.
Bagley G
Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
[No Abstract] [Full Text] [Related]
37. Clinical trials: some ethical issues.
Srinivasan S
Issues Med Ethics; 1998 Apr; 6(2):45-6. PubMed ID: 15011699
[No Abstract] [Full Text] [Related]
38. Compounding risks to patients: selective disclosure is not an option.
McGoey L
Am J Bioeth; 2009 Aug; 9(8):35-6. PubMed ID: 19998156
[No Abstract] [Full Text] [Related]
39. Research on anti-fertility vaccines: serious concerns for women's health.
Saheli Women's Health Centre
Issues Med Ethics; 2000; 8(2):51-2. PubMed ID: 16323345
[No Abstract] [Full Text] [Related]
40. The exclusion of pregnant, pregnable, and once-pregnable people (a.k.a. women) from biomedical research.
Merton V
Am J Law Med; 1993; 19(4):369-451. PubMed ID: 7942864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]